Invalid Symbol

Stock Research for OCRX

Current Price


Latest Update:


Featured Broker: TradeStation

Get the due diligence for another stock.


OCRX Stock Chart & Research Data

The OCRX chart settings shown below allow you to select time intervals of 1 min, 30 mins, an hour or by day - week - month. There is also the ability to change the OCRX chart style to candles, hollow candles, bars, lines or add various indicators. You can even add a symbol and compare history.


OCRX Due diligence Resources & Stock Charts

The OCRX stock resources shown below were gathered to cut back on time by allowing you to visit multiple sites at once. For your convenience each link clicked will open in a window. In addition to the individual links there is a button at the bottom that will allow you to open all the links at the same time. Note opening all links at once may not work with all browsers. Some browsers block multiple windows, to resolve this please allow that site to use pop-ups.

The Four Most Popular Resources

CNN View OCRX Detailed Price Forecast - CNN Money CNN View OCRX Detailed Summary - Google Finance
Yahoo View OCRX Detailed Summary - Yahoo! Finance Zacks View OCRX Stock Research & Analysis -

Stock Analysis

TradeIdeas View OCRX Trends & Analysis - Trade-Ideas Barrons View OCRX Major Holders - Barrons
NASDAQ View OCRX Call Transcripts - NASDAQ Seeking View OCRX Breaking News & Analysis - Seeking Alpha
Spotlight View OCRX Annual Report - OTC Report View OCRX OTC Short Report -
TradeKing View OCRX Fundamentals - TradeKing Charts View OCRX SEC Filings - Bar Chart
WSJ View Historical Prices for OCRX - The WSJ Morningstar View Performance/Total Return for OCRX - Morningstar
MarketWatch View the Analyst Estimates for OCRX - MarketWatch CNBC View the Earnings History for OCRX - CNBC
StockMarketWatch View the OCRX Earnings - StockMarketWatch MacroAxis View OCRX Buy or Sell Recommendations - MacroAxis
Bullish View the OCRX Bullish Patterns - American Bulls Short Pains View OCRX Short Pain Metrics -

Social Media Mentions

StockTwits View OCRX Stock Mentions - StockTwits PennyStocks View OCRX Stock Mentions - PennyStockTweets
Twitter View OCRX Stock Mentions - Twitter Invest Hub View OCRX Investment Forum News - Investor Hub
Yahoo View OCRX Stock Mentions - Yahoo! Message Board Seeking Alpha View OCRX Stock Mentions - Seeking Alpha

Financial & Transaction Holdings

SECform4 View Insider Transactions for OCRX - Insider Cow View Insider Transactions for OCRX - Insider Cow
CNBC View OCRX Major Holdings Summary - CNBC OTC Markets View Insider Disclosure for OCRX - OTC Markets
Yahoo View Insider Transactions for OCRX - Yahoo! Finance NASDAQ View Institutional Holdings for OCRX - NASDAQ

Stock Charts

FinViz View OCRX Stock Insight & Charts - StockCharts View OCRX Investment Charts -
BarChart View OCRX Stock Overview & Charts - BarChart Trading View View OCRX User Generated Charts - Trading View

Latest Financial News for OCRX

Want To Invest In Ocera Therapeutics Inc (undefined:OCRX)? Here’s How It Performed Lately
Posted on Wednesday December 13, 2017

For investors with a long-term horizon, assessing earnings trend over time and against industry benchmarks is more valuable than looking at a single earnings announcement in one point in time.Read More...

At $1.75, Is It Time To Buy Ocera Therapeutics Inc (OCRX)?
Posted on Friday November 17, 2017

Ocera Therapeutics Inc (NASDAQ:OCRX), a pharmaceuticals company based in United States, saw a significant share price rise of over 20% in the past couple of months on the NasdaqCM. LessRead More...

Lifshitz & Miller LLP Announces Investigation of Manitex International, Inc., Novan, Inc., Ocera Therapeutics, Inc., Planet Payment, Inc., RE/MAX Holdings, Inc., Super Micro Computer, Inc. and World Acceptance Corporation
Posted on Thursday November 16, 2017

NEW YORK , Nov. 16, 2017 /PRNewswire/ -- Manitex International, Inc. (MNTX) Lifshitz & Miller announces an investigation on behalf of MNTX investors after MNTX disclosed that certain of its financial statements ...

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of Ocera Therapeutics, Inc. - OCRX
Posted on Thursday November 02, 2017

NEW YORK , Nov. 2, 2017 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a boutique securities firm headquartered at the Empire State Building in New York ...

Ocera Therapeutics: Major Risk, Great Upside Potential
Seeking Alpha - Mar 10, 2017
On March 9, 2017, Ocera Therapeutics (NASDAQ:OCRX) was trading at $1.89, a whopping 315% spike from its share price on the March 7, 2017.
Moving on Up: Ocera Therapeutics Inc (OCRX), Aurinia Pharmaceuticals Inc (AUPH) - Smarter Analyst
Ocera Therapeutics, Inc. (NASDAQ:OCRX) Turns on Same Data That Sank Shares - StockNewsUnion

Ocera Therapeutics: When A Drug Fails, But Actually Works
Seeking Alpha - Aug 8, 2017
Ocera Therapeutics (OCRX) is a clinical stage biopharmaceutical company, focused primarily on developing OCR-002 (ornithine phenylacetate) for the treatment of hepatic encephalopathy.

SHAREHOLDER ALERT: Monteverde & Associates PC Announces An Investigation Of ...
PR Newswire (press release) - Nov 3, 2017
NEW YORK, Nov. 2, 2017 /PRNewswire/ -- Juan Monteverde, founder and managing partner at Monteverde & Associates PC, a boutique securities firm headquartered at the Empire State Building in New York City, is investigating Ocera Therapeutics, Inc ...

Mallinckrodt to Acquire Ocera Therapeutics for Up to $117M
Genetic Engineering & Biotechnology News - Nov 2, 2017
Mallinckrodt has agreed to acquire Ocera Therapeutics for up to $117 million, the companies said today, in a deal that would boost the buyer's pipeline in treatments for orphan and other liver and kidney diseases.

Enter a stock symbol to view the stock details.